Bicycle Therapeutics

E422484

Bicycle Therapeutics is a biotechnology company that develops novel therapeutics based on its proprietary bicyclic peptide (Bicycle®) platform, with a focus on targeted treatments for cancer and other serious diseases.

All labels observed (1)

Label Occurrences
Bicycle Therapeutics canonical 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biotechnology company ⓘ
public company ⓘ
countryOfOrigin United Kingdom ⓘ
develops Bicycle molecules ⓘ
bicyclic peptide therapeutics ⓘ
focusesOn cancer therapeutics ⓘ
oncology ⓘ
targeted therapies ⓘ
foundedBy Christian Heinis ⓘ
Gregory Winter ⓘ
Ian Tomlinson ⓘ
foundedInPeriod late 2000s ⓘ
hasClinicalCandidate BT1718 ⓘ
BT5528 ⓘ
BT7480 ⓘ
BT8009 ⓘ
hasCollaboration AstraZeneca ⓘ
Cancer Research UK ⓘ
Ionis Pharmaceuticals ⓘ
Novartis ⓘ
hasIntellectualProperty proprietary Bicycle peptide platform ⓘ
hasKeyPerson Kevin Lee ⓘ
hasOffice Cambridge, Massachusetts, United States ⓘ
hasTechnologyPlatform Bicycle peptide platform ⓘ
hasTherapeuticArea other serious diseases ⓘ
solid tumor cancers ⓘ
headquartersLocation Cambridge, United Kingdom ⓘ
linked to: Cambridge, England
industry biotechnology ⓘ
mission to develop targeted therapeutics for cancer and other serious diseases ⓘ
positionHeld Kevin Lee – Chief Executive Officer ⓘ
researchArea hematologic malignancies ⓘ
immuno-oncology ⓘ
solid tumors ⓘ
specializesIn bicyclic peptides ⓘ
chemically constrained peptides ⓘ
stockTicker BCYC ⓘ
targets EphA2 (via BT5528) ⓘ
MT1-MMP (via BT1718) ⓘ
Nectin-4 (via BT8009) ⓘ
Nectin-4/CD137 (via BT7480) ⓘ
technologyCharacteristic high affinity target binding ⓘ
rapid clearance from circulation ⓘ
rapid tissue penetration ⓘ
small, chemically synthesized peptides ⓘ
tradesOn NASDAQ ⓘ
usesApproach phage display for peptide discovery ⓘ
usesModality tumor-targeted immune cell agonists ⓘ
tumor-targeted radioconjugates ⓘ
tumor-targeted toxin conjugates ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

Cambridge life sciences ecosystem → hasKeyCompany → Bicycle Therapeutics ⓘ